Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes - PubMed (original) (raw)
. 1997 Jun 15;158(12):5783-90.
Affiliations
- PMID: 9190929
Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes
V R Sutton et al. J Immunol. 1997.
Abstract
Two pathways have been implicated in the induction of apoptosis by cytotoxic T cells: the granule exocytosis pathway and a pathway using CD95 (Fas/APO-1). To test whether apoptosis induced by either of these pathways could be blocked by Bcl-2, we exposed bcl-2-transfected cells to CTL derived from normal, perforin-deficient, or CD95 ligand mutant (gld) mice. Although the levels of Bcl-2 expression achieved were able to protect FDC-P1 and Yac-1 transfectants from a variety of apoptotic stimuli, the cells were not protected from cytolysis mediated by CTL from any of these sources, by NK cells, or granules isolated from CTL. However, Bcl-2 expression significantly inhibited apoptosis induced by purified granzyme B and perforin. These results suggest that while Bcl-2 is capable of inhibiting the apoptotic pathway utilized by perforin and granzyme B, other granule components can bypass this block. We conclude that CTL harbor potent killing mechanism(s) in addition to those provided by CD95 ligand or perforin and granzyme B that cannot be overcome by Bcl-2.
Similar articles
- Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2.
Schröter M, Lowin B, Borner C, Tschopp J. Schröter M, et al. Eur J Immunol. 1995 Dec;25(12):3509-13. doi: 10.1002/eji.1830251245. Eur J Immunol. 1995. PMID: 8566045 - Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
Anel A, Gamen S, Alava MA, Schmitt-Verhulst AM, Piñeiro A, Naval J. Anel A, et al. J Immunol. 1997 Mar 1;158(5):1999-2006. J Immunol. 1997. PMID: 9036942 - The mechanism of organophosphorus pesticide-induced inhibition of cytolytic activity of killer cells.
Li Q, Kawada T. Li Q, et al. Cell Mol Immunol. 2006 Jun;3(3):171-8. Cell Mol Immunol. 2006. PMID: 16893497 Review. - Functional significance of the perforin/granzyme cell death pathway.
Trapani JA, Smyth MJ. Trapani JA, et al. Nat Rev Immunol. 2002 Oct;2(10):735-47. doi: 10.1038/nri911. Nat Rev Immunol. 2002. PMID: 12360212 Review.
Cited by
- Host immune responses against African swine fever virus: Insights and challenges for vaccine development.
Orosco FL. Orosco FL. Open Vet J. 2023 Dec;13(12):1517-1535. doi: 10.5455/OVJ.2023.v13.i12.2. Epub 2023 Dec 31. Open Vet J. 2023. PMID: 38292721 Free PMC article. Review. - The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells.
Copertino DC Jr, Holmberg CS, Weiler J, Ward AR, Howard JN, Levinger C, Pang AP, Corley MJ, Dündar F, Zumbo P, Betel D, Gandhi RT, McMahon DK, Bosch RJ, Linden N, Macatangay BJ, Cyktor JC, Eron JJ, Mellors JW, Kovacs C, Benko E, Bosque A, Jones RB; AIDS Clinical Trials Group (ACTG) A5321 Team. Copertino DC Jr, et al. JCI Insight. 2023 Sep 22;8(18):e169028. doi: 10.1172/jci.insight.169028. JCI Insight. 2023. PMID: 37581929 Free PMC article. - The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model.
Chandrasekar AP, Cummins NW, Natesampillai S, Misra A, Alto A, Laird G, Badley AD. Chandrasekar AP, et al. J Virol. 2022 Dec 21;96(24):e0173022. doi: 10.1128/jvi.01730-22. Epub 2022 Nov 30. J Virol. 2022. PMID: 36448802 Free PMC article. - Prime, shock and kill: BCL-2 inhibition for HIV cure.
Chandrasekar AP, Badley AD. Chandrasekar AP, et al. Front Immunol. 2022 Oct 20;13:1033609. doi: 10.3389/fimmu.2022.1033609. eCollection 2022. Front Immunol. 2022. PMID: 36341439 Free PMC article. Review. - Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity.
Tuomela K, Ambrose AR, Davis DM. Tuomela K, et al. Front Immunol. 2022 Mar 23;13:867098. doi: 10.3389/fimmu.2022.867098. eCollection 2022. Front Immunol. 2022. PMID: 35401556 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous